vs
Kodiak Gas Services, Inc.（KGS）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Kodiak Gas Services, Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.6倍（$332.9M vs $207.3M），Kodiak Gas Services, Inc.净利率更高（7.4% vs -62.0%，领先69.4%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 7.5%），Kodiak Gas Services, Inc.自由现金流更多（$142.0M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 24.3%）
Kodiak Gas Services是北美知名的天然气压缩服务供应商，主要服务油气行业上下游客户，提供定制化压缩设备、运维及运营支持，帮助客户优化陆上天然气收集、处理与运输全流程的运营效率。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
KGS vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $332.9M | $207.3M |
| 净利润 | $24.6M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 26.1% | -54.7% |
| 净利率 | 7.4% | -62.0% |
| 营收同比 | 7.5% | 25.9% |
| 净利润同比 | 29.0% | 3.5% |
| 每股收益（稀释后） | $0.30 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $332.9M | $207.3M | ||
| Q3 25 | $322.7M | $159.9M | ||
| Q2 25 | $322.8M | $166.5M | ||
| Q1 25 | $329.6M | $139.3M | ||
| Q4 24 | $309.5M | $164.6M | ||
| Q3 24 | $324.6M | $139.5M | ||
| Q2 24 | $309.7M | $147.0M | ||
| Q1 24 | $215.5M | $108.8M |
| Q4 25 | $24.6M | $-128.6M | ||
| Q3 25 | $-14.0M | $-180.4M | ||
| Q2 25 | $39.5M | $-115.0M | ||
| Q1 25 | $30.4M | $-151.1M | ||
| Q4 24 | $19.1M | $-133.2M | ||
| Q3 24 | $-5.6M | $-133.5M | ||
| Q2 24 | $6.2M | $-131.6M | ||
| Q1 24 | $30.2M | $-170.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 37.5% | — | ||
| Q2 24 | 36.5% | — | ||
| Q1 24 | 39.4% | — |
| Q4 25 | 26.1% | -54.7% | ||
| Q3 25 | 19.9% | -106.9% | ||
| Q2 25 | 30.9% | -64.8% | ||
| Q1 25 | 27.1% | -102.6% | ||
| Q4 24 | 22.3% | -74.3% | ||
| Q3 24 | 20.4% | -94.6% | ||
| Q2 24 | 17.5% | -79.1% | ||
| Q1 24 | 27.9% | -151.9% |
| Q4 25 | 7.4% | -62.0% | ||
| Q3 25 | -4.3% | -112.8% | ||
| Q2 25 | 12.2% | -69.0% | ||
| Q1 25 | 9.2% | -108.5% | ||
| Q4 24 | 6.2% | -80.9% | ||
| Q3 24 | -1.7% | -95.7% | ||
| Q2 24 | 2.0% | -89.5% | ||
| Q1 24 | 14.0% | -156.8% |
| Q4 25 | $0.30 | $-1.28 | ||
| Q3 25 | $-0.17 | $-1.81 | ||
| Q2 25 | $0.43 | $-1.17 | ||
| Q1 25 | $0.33 | $-1.57 | ||
| Q4 24 | $0.18 | $-1.34 | ||
| Q3 24 | $-0.07 | $-1.40 | ||
| Q2 24 | $0.06 | $-1.52 | ||
| Q1 24 | $0.39 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.2M | $421.0M |
| 总债务越低越好 | $2.6B | — |
| 股东权益账面价值 | $1.2B | $-80.0M |
| 总资产 | $4.3B | $1.5B |
| 负债/权益比越低杠杆越低 | 2.12× | — |
8季度趋势，按日历期对齐
| Q4 25 | $3.2M | $421.0M | ||
| Q3 25 | $724.0K | $202.5M | ||
| Q2 25 | $5.4M | $176.3M | ||
| Q1 25 | $1.9M | $127.1M | ||
| Q4 24 | $4.8M | $174.0M | ||
| Q3 24 | $7.4M | $150.6M | ||
| Q2 24 | $3.9M | $480.7M | ||
| Q1 24 | $9.3M | $112.3M |
| Q4 25 | $2.6B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.6B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.5B | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $-80.0M | ||
| Q3 25 | $1.3B | $9.2M | ||
| Q2 25 | $1.3B | $151.3M | ||
| Q1 25 | $1.4B | $144.2M | ||
| Q4 24 | $1.4B | $255.0M | ||
| Q3 24 | $1.4B | $346.8M | ||
| Q2 24 | $1.5B | $432.4M | ||
| Q1 24 | $1.1B | $140.3M |
| Q4 25 | $4.3B | $1.5B | ||
| Q3 25 | $4.4B | $1.2B | ||
| Q2 25 | $4.4B | $1.3B | ||
| Q1 25 | $4.4B | $1.3B | ||
| Q4 24 | $4.4B | $1.5B | ||
| Q3 24 | $4.5B | $1.5B | ||
| Q2 24 | $4.4B | $1.6B | ||
| Q1 24 | $3.3B | $1.3B |
| Q4 25 | 2.12× | — | ||
| Q3 25 | 2.08× | — | ||
| Q2 25 | 1.89× | — | ||
| Q1 25 | 1.91× | — | ||
| Q4 24 | 1.88× | — | ||
| Q3 24 | 1.86× | — | ||
| Q2 24 | 1.71× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $194.9M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $142.0M | $-100.8M |
| 自由现金流率自由现金流/营收 | 42.7% | -48.6% |
| 资本支出强度资本支出/营收 | 15.9% | 0.5% |
| 现金转化率经营现金流/净利润 | 7.91× | — |
| 过去12个月自由现金流最近4个季度 | $284.3M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $194.9M | $-99.8M | ||
| Q3 25 | $113.4M | $-91.4M | ||
| Q2 25 | $177.2M | $-108.3M | ||
| Q1 25 | $114.3M | $-166.5M | ||
| Q4 24 | $118.5M | $-79.3M | ||
| Q3 24 | $36.9M | $-67.0M | ||
| Q2 24 | $121.1M | $-77.0M | ||
| Q1 24 | $51.5M | $-190.7M |
| Q4 25 | $142.0M | $-100.8M | ||
| Q3 25 | $10.9M | $-92.7M | ||
| Q2 25 | $94.6M | $-110.7M | ||
| Q1 25 | $36.8M | $-167.8M | ||
| Q4 24 | $45.2M | $-79.5M | ||
| Q3 24 | $-49.7M | $-68.6M | ||
| Q2 24 | $4.0M | $-79.0M | ||
| Q1 24 | $-8.6M | $-193.9M |
| Q4 25 | 42.7% | -48.6% | ||
| Q3 25 | 3.4% | -58.0% | ||
| Q2 25 | 29.3% | -66.5% | ||
| Q1 25 | 11.2% | -120.5% | ||
| Q4 24 | 14.6% | -48.3% | ||
| Q3 24 | -15.3% | -49.2% | ||
| Q2 24 | 1.3% | -53.7% | ||
| Q1 24 | -4.0% | -178.2% |
| Q4 25 | 15.9% | 0.5% | ||
| Q3 25 | 31.7% | 0.8% | ||
| Q2 25 | 25.6% | 1.5% | ||
| Q1 25 | 23.5% | 1.0% | ||
| Q4 24 | 23.7% | 0.1% | ||
| Q3 24 | 26.7% | 1.2% | ||
| Q2 24 | 37.8% | 1.4% | ||
| Q1 24 | 27.9% | 3.0% |
| Q4 25 | 7.91× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.49× | — | ||
| Q1 25 | 3.76× | — | ||
| Q4 24 | 6.21× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 19.44× | — | ||
| Q1 24 | 1.70× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KGS
| Other Services | $126.8M | 38% |
| Other | $112.2M | 34% |
| Transferred At Point In Time | $93.8M | 28% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
